<SEC-DOCUMENT>0001104659-23-105925-index.html : 20231002
<SEC-HEADER>0001104659-23-105925.hdr.sgml : 20231002
<ACCEPTANCE-DATETIME>20231002163908
ACCESSION NUMBER:		0001104659-23-105925
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20230928
FILED AS OF DATE:		20231002
DATE AS OF CHANGE:		20231002

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Fitzgerald Thomas A
		CENTRAL INDEX KEY:			0001854168

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40363
		FILM NUMBER:		231300246

	MAIL ADDRESS:	
		STREET 1:		C/O TRANSCODE THERAPEUTICS, INC.
		STREET 2:		6 LIBERTY SQUARE, #2382
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02109

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Transcode Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001829635
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				811065054
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		6 LIBERTY SQUARE
		STREET 2:		#2382
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02109
		BUSINESS PHONE:		857-301-6857

	MAIL ADDRESS:	
		STREET 1:		6 LIBERTY SQUARE
		STREET 2:		#2382
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02109
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>tm2327413d2_4seq1.xml
<DESCRIPTION>OWNERSHIP DOCUMENT
<TEXT>
Document 1 - file: tm2327413d2_4seq1.html

Document 1 - RAW XML: tm2327413d2_4seq1.xml

</DOCUMENT>
</SEC-DOCUMENT>